All indicators up for Zoll in Q2
Zoll Medical, a manufacturer of resuscitation devices and software, has posted positive incomes and revenues for the second quarter of 2010, which ended March 31.
Net income was $3.7 million for the quarter, an increase of 105 percent, compared to $1.8 million in the prior year, according to the Chelmsford, Mass.-based company. Backlog at the end of the second quarter was approximately $22.2 million, as compared to approximately $8 million at the end of the second quarter 2009.
The revenues for the second quarter of fiscal 2010 increased 15 percent to $107.1 million, compared to revenues in the second quarter of last year of $92.7 million, Zoll reported. The revenue results included a positive foreign exchange impact of approximately $2.2 million, compared to the second quarter of fiscal 2009. The results also included approximately $4 million of revenue derived from the temperature management business, whose assets were acquired from Alsius in May 2009.
The company said its second quarter sales to the North American market were $81 million, an increase of 16 percent, compared to $70.1 million for the prior-year period. Sales to the North American hospital market, including $2.3 million related to the temperature management business, increased 41 percent to $24.7 million, compared to $17.5 million for the same period last year.
Net income was $3.7 million for the quarter, an increase of 105 percent, compared to $1.8 million in the prior year, according to the Chelmsford, Mass.-based company. Backlog at the end of the second quarter was approximately $22.2 million, as compared to approximately $8 million at the end of the second quarter 2009.
The revenues for the second quarter of fiscal 2010 increased 15 percent to $107.1 million, compared to revenues in the second quarter of last year of $92.7 million, Zoll reported. The revenue results included a positive foreign exchange impact of approximately $2.2 million, compared to the second quarter of fiscal 2009. The results also included approximately $4 million of revenue derived from the temperature management business, whose assets were acquired from Alsius in May 2009.
The company said its second quarter sales to the North American market were $81 million, an increase of 16 percent, compared to $70.1 million for the prior-year period. Sales to the North American hospital market, including $2.3 million related to the temperature management business, increased 41 percent to $24.7 million, compared to $17.5 million for the same period last year.